Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine + Carbamazepine in Bipolar I Mania
NCT00190892Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of olanzapine in bipolar I disorder, sponsored by Eli Lilly and Company. Started Sep 2004; status: completed.
02
Drugs
olanzapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00190892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190892.